Inpharma Weekly

, Volume 1641, Issue 1, pp 15–15 | Cite as

VEGF + EGFR = no extra benefit

Clinical study
  • 4 Downloads

Keywords

Vascular Endothelial Growth Factor Epidermal Growth Factor Receptor Bevacizumab Oxaliplatin Capecitabine 

Copyright information

© Adis International Ltd 2008

Personalised recommendations